When should step-down therapy be considered in the management of inflammatory bowel disease (IBD)?

Updated: Apr 10, 2020
  • Author: William A Rowe, MD; Chief Editor: BS Anand, MD  more...
  • Print

Aggressive therapy should be considered early in the management of patients with difficult or refractory inflammatory bowel disease (IBD). This approach uses immune modifiers and/or anti-tumor necrosis factor (TNF) agents earlier in the treatment of the IBD patient (see Overview of Therapy).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!